Summit Trail Advisors LLC Decreases Stock Holdings in Houlihan Lokey, Inc. (NYSE:HLI)

Summit Trail Advisors LLC lowered its position in Houlihan Lokey, Inc. (NYSE:HLIFree Report) by 3.8% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 4,907 shares of the financial services provider’s stock after selling 196 shares during the period. Summit Trail Advisors LLC’s holdings in Houlihan Lokey were worth $775,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of HLI. Opal Wealth Advisors LLC acquired a new stake in Houlihan Lokey in the second quarter valued at approximately $26,000. Crewe Advisors LLC boosted its position in shares of Houlihan Lokey by 264.5% in the 2nd quarter. Crewe Advisors LLC now owns 226 shares of the financial services provider’s stock worth $30,000 after purchasing an additional 164 shares in the last quarter. Wolff Wiese Magana LLC purchased a new position in Houlihan Lokey during the 3rd quarter worth $38,000. Ashton Thomas Private Wealth LLC acquired a new position in Houlihan Lokey during the 2nd quarter valued at about $38,000. Finally, First Horizon Advisors Inc. raised its stake in Houlihan Lokey by 81.5% in the third quarter. First Horizon Advisors Inc. now owns 441 shares of the financial services provider’s stock valued at $70,000 after buying an additional 198 shares during the last quarter. Hedge funds and other institutional investors own 78.07% of the company’s stock.

Insider Activity

In other news, Director Gillian Beth Zucker sold 200 shares of the firm’s stock in a transaction dated Monday, October 14th. The stock was sold at an average price of $168.08, for a total transaction of $33,616.00. Following the sale, the director now directly owns 6,601 shares in the company, valued at $1,109,496.08. This trade represents a 2.94 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, General Counsel Christopher M. Crain sold 1,000 shares of the company’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $155.29, for a total value of $155,290.00. The disclosure for this sale can be found here. Insiders sold a total of 1,400 shares of company stock valued at $219,362 in the last three months. 23.68% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on HLI shares. StockNews.com lowered Houlihan Lokey from a “buy” rating to a “hold” rating in a research note on Wednesday, November 20th. Wells Fargo & Company started coverage on shares of Houlihan Lokey in a research note on Thursday, September 12th. They set an “underweight” rating and a $149.00 price objective for the company. Keefe, Bruyette & Woods reissued a “market perform” rating and issued a $154.00 target price (up from $139.00) on shares of Houlihan Lokey in a research report on Wednesday, July 31st. JPMorgan Chase & Co. lowered their price target on Houlihan Lokey from $132.00 to $129.00 and set a “neutral” rating for the company in a research report on Wednesday, July 31st. Finally, UBS Group boosted their price target on Houlihan Lokey from $170.00 to $190.00 and gave the company a “buy” rating in a research note on Tuesday, October 8th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $157.00.

Get Our Latest Stock Report on HLI

Houlihan Lokey Price Performance

NYSE HLI opened at $190.49 on Tuesday. Houlihan Lokey, Inc. has a 1 year low of $104.86 and a 1 year high of $192.10. The company has a market capitalization of $13.24 billion, a PE ratio of 38.96 and a beta of 0.65. The company has a fifty day moving average of $170.99 and a 200 day moving average of $152.11.

Houlihan Lokey (NYSE:HLIGet Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $1.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.31 by $0.15. The business had revenue of $574.96 million during the quarter, compared to analysts’ expectations of $537.93 million. Houlihan Lokey had a return on equity of 19.29% and a net margin of 15.77%. The company’s revenue for the quarter was up 23.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.11 EPS. Research analysts expect that Houlihan Lokey, Inc. will post 5.79 earnings per share for the current year.

Houlihan Lokey Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Sunday, December 15th. Stockholders of record on Monday, December 2nd will be paid a dividend of $0.57 per share. The ex-dividend date of this dividend is Monday, December 2nd. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.20%. Houlihan Lokey’s payout ratio is 46.63%.

Houlihan Lokey Profile

(Free Report)

Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.

See Also

Want to see what other hedge funds are holding HLI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Houlihan Lokey, Inc. (NYSE:HLIFree Report).

Institutional Ownership by Quarter for Houlihan Lokey (NYSE:HLI)

Receive News & Ratings for Houlihan Lokey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Houlihan Lokey and related companies with MarketBeat.com's FREE daily email newsletter.